Showing results (471-480 of 583) with videos related to

Sort By:
Pageof 59
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|March 14, 2014
Minimally invasive total pharyng-laryngo-esophagectomy and reconstruction with gastric tube: report of three casesYasue Kimura, Masaru Morita, Hiroshi Saeki, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|March 14, 2014
Relevance of totally laparoscopic gastrectomy for patients with advanced gastric cancerHiroshi Saeki, Eiji Oki, Yasuo Tsuda, et al.
Surgical Endoscopy|November 7, 2023
Real-time telementoring with 3D drawing annotation in robotic surgeryTomonori Nakanoko, Eiji Oki, Mitsuhiko Ota, et al.
Cancer Science|June 19, 2025
Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC ExpressionKosuke Hirose, Takaaki Masuda, Hajime Otsu, et al.
British Journal of Cancer|July 10, 2019
Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)Eiji Oki, Yasunori Emi, Takeharu Yamanaka, et al.
Cancer Medicine|December 4, 2020
Comprehensive molecular profiling broadens treatment options for breast cancer patientsHitomi Kawaji, Makoto Kubo, Nami Yamashita, et al.
Clinical Colorectal Cancer|March 14, 2018
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO StudyEiji Oki, Takeshi Kato, Hideaki Bando, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|December 25, 2013
Total laparoscopic distal gastrectomy for elderly patients with gastric cancerEiji Oki, Yoshihisa Sakaguchi, Kippei Ohgaki, et al.
International Journal of Clinical Oncology|January 29, 2015
Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III studyEiji Oki, Yasunori Emi, Hiroshi Kojima, et al.
BMC Cancer|December 15, 2021
Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patientsEiji Oki, Eiji Shinto, Mototsugu Shimokawa, et al.
Pageof 59